Molecular biomarkers for autoimmune retinopathies: Significance of anti-transducin-alpha autoantibodies

Experimental and Molecular Pathology

Volumn 87, Issue 3, 2009, Pages 195-203

  Adamus, Grazyna ^a   Brown, Lori ^a   Weleber, Richard G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Autoantibody; Autoimmunity; Biomarker; Retinopathy; Transducin

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; TRANSDUCIN ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; ELECTRORETINOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; PHOTORECEPTOR; PROGNOSIS; RETINA CONE; RETINA DEGENERATION; RETINA ROD; RETINOPATHY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL DEGENERATION; TRANSDUCIN;

EID: 70350783854     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.08.003     Document Type: Article

References (39)

1. Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun. Rev. 2 (2003) 63-69
2. Adamus G. The role of recoverin in autoimmunity. In: Philippov P.P., and Koch K.W. (Eds). Neuronal Calcium Sensor Protein (2006), Nova Science Publisher, Inc., New York 181-200
3. Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun. Rev. 8 5 (2009) 410-414
4. Adamus G., and Karren L. Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. J. Autoimmun. 32 2 (2009) 133-139
5. Adamus G., Guy J., Schmied J.L., Arendt A., and Hargrave P.A. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2626-2633
6. Adamus G., Aptsiauri N., Guy J., Heckenlively J., Flannery J., and Hargrave P.A. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin. Immunol. Immunopath. 78 (1996) 120-129
7. Adamus G., Machnicki M., and Seigel G.M. Apoptotic retinal cell death induced by autoantibodies of cancer associated retinopathy. Inves. Ophthal. Vis. Sci. 38 (1997) 283-291
8. Adamus G., Amundson D., MacKay C., and Gouras P. Long-term persistence of anti-recoverin autoantibodies in endometrial cancer-associated retinopathy. Arch. Ophthalmol. 116 (1998) 251-253
9. Adamus G., Ren G., and Weleber R.G. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 4 1 (2004) 5
10. Bazhin A.V., Savchenko M.S., Shifrina O.N., Demoura S.A., Chikina S.Y., Jaques G., Kogan E.A., Chuchalin A.G., and Philippov P.P. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung Cancer 44 2 (2004) 193-198
11. Bazhin A.V., Schadendorf D., Willner N., Smet C.D., Heinzelmann A., Tikhomirova N.K., Umansky V., Philippov P.P., and Eichmüller S.B. Photoreceptor proteins as cancer-retina antigens. Int. J. Cancer 120 6 (2007) 1268-1276
12. Dryja T.P., Hahn L.B., Reboul T., and Arnaud B. Missense mutation in the gene encoding the [alpha] subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat. Genet. 13 3 (1996) 358-360
13. Heckenlively J., and Ferreyra H. Autoimmune retinopathy: a review and summary. Sem. Immunopathol. 30 2 (2008) 127-134
14. Itoh H., Toyama R., Kozasa T., Tsukamoto T., Matsuoka M., and Kaziro Y. Presence of three distinct molecular species of Gi protein alpha subunit. Structure of rat cDNAs and human genomic DNAs. J. Biol. Chem. 263 14 (1988) 6656-6664
15. Jacobson D.M. Paraneoplastic disorders of neuro-ophthalmologic interest. Curr. Opin. Ophthalmol. 7 (1996) 30-38
16. Jacobson D.M., Thirkill C.E., and Tipping S.J. A clinical triad to diagnose paraneoplastic retinopathy. Ann. Neurol. 28 (1990) 162-167
17. Keltner J.L., and Thirkill C.E. The 22-kDa antigen in optic nerve and retinal diseases. J. Neuroophthalmol. 19 (1999) 71-83
18. Khan N., Huang J.J., and Foster C.S. Cancer associated retinopathy (CAR): an autoimmune-mediated paraneoplastic syndrome. Semin. Ophthalmol. 21 3 (2006) 135-141
19. Kobayashi M., Ikezoe T., Uemura Y., Ueno H., and Taguchi H. Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy. Lung Cancer 57 3 (2007) 399-403
20. Lania A.G., Mantovani G., and Spada A. Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases. Nature Clinical Practice Endocrinol. Metabol. 2 12 (2006) 681-693
21. Lem J., and Fain G.L. Constitutive opsin signaling: night blindness or retinal degeneration?. Trends Mol. Med. 10 4 (2004) 150-157
22. Ma J.-x., Znoiko S., Othersen K.L., Ryan J.C., Das J., Isayama T., Kono M., Oprian D.D., Corson D.W., Cornwall M.C., Cameron D.A., Harosi F.I., Makino C.L., and Crouch R.K. A visual pigment expressed in both rod and cone photoreceptors. Neuron 32 3 (2001) 451-461
23. Maeda T., Maeda A., Maruyama I., Ogawa K.I., Kuroki Y., Sahara H., Sato N., and Ohguro H. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 42 3 (2001) 705-712
24. Mantel I., Ramchand K.V., Holder G.E., Ohbayashi M., Morohoshi K., Patel N., Toda M., Fitzke F.W., Bird A.C., and Ono S.J. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology. Exp. Mol. Pathol. 84 2 (2008) 90-101
25. Meurs K.P.V., Angus C.W., Lavu S., Kung H.-F., Czarnecki S.K., Moss J., and Vaughan M. Deduced amino acid sequence of bovine retinal G{oalpha}: similarities to other guanine nucleotide-binding proteins. Proc. Natl. Acad. Sci. U.S.A. 84 10 (1987) 3107-3111
26. Navon S., and Fung B. Characterization of transducin from bovine retinal rod outer segments. Use of monoclonal antibodies to probe the structure and function of the subunit. J. Biol. Chem. 263 1 (1988) 489-496
27. Ohguro H., and Nakazawa M. Pathological roles of recoverin in cancer-associated retinopathy. Adv. Exp. Med. Biol. 514 (2002) 109-124
28. Ohguro H., Yokoi Y., Ohguro I., Mamiya K., Ishikawa F., Yamazaki H., Metoki T., Takano Y., Ito T., and Nakazawa M. Clinical and immunologic aspects of cancer-associated retinopathy. Am. J. Ophthalmol. 137 6 (2004) 1117-1119
29. Oohira A. Fifteen-year follow-up of patient with cancer-associated retinopathy. Jpn. J. Ophthalmol. 51 1 (2007) 74-75
30. Parc C.E., Azan E., Bonnel S., Sahel J.A., Kaplan J., and Thirkill C.E. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kilodalton. Ophthalmic Genet. 27 2 (2006) 57-61
31. Peek R., Dijkstra B.G., Meek B., and Kuijpers R.W. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy. Clin. Exp. Immunol. 128 3 (2002) 498-503
32. Polans A.S., Buczylko J., Crabb J., and Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J. Cell. Biol. 112 5 (1991) 981-989
33. Polans A., Witkowska D., Haley T., Amundson D., Baizer L., and Adamus G. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9176-9180
34. Potter M.J., Adamus G., Szabo S.M., Lee R., Mohaseb K., and Behn D. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am. J. Ophthalmol. 134 1 (2002) 128-130
35. Ridge K.D., and Palczewski K. Visual rhodopsin sees the light: structure and mechanism of G protein signaling. J. Biol. Chem. 282 13 (2007) 9297-9301
36. Ristic H., Srinivasan S., Hall K.E., Sima A.A.F., and Wiley J.W. Serum from diabetic BB/W rats enhances calcium currents in primary sensory neurons. J. Neurophysiol. 80 3 (1998) 1236-1244
37. Tan E., Ding X.Q., Saadi A., Agarwal N., Naash M.I., and Al-Ubaidi M.R. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest. Ophthalmol. Vis. Sci. 45 3 (2004) 764-768
38. Thirkill C.E., Tait R.C., Tyler N.K., Roth A.M., and Keltner J.L. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2768-2772
39. Weleber R.G., Watzke R.C., Shults W.T., Trzupek K.M., Heckenlively J.R., Egan R.A., and Adamus G. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am. J. Ophthalmol. 139 5 (2005) 780-794